Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,208,599
-$203,235 QoQ
Shares Held
50,191
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,209
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. PFE ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
This page
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,208,599 | 50,191 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,411,834 | 50,279 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,311,756 | 52,681 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,354,287 | 53,151 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,510,394 | 62,310 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,702,695 | 67,194 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,007,312 | 75,662 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,328,859 | 80,472 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,270,604 | 81,151 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,463,978 | 88,792 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,246,619 | 112,769 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,821,150 | 115,199 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,544,431 | 123,894 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,025,254 | 123,168 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,213,618 | 121,265 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $5,409,173 | 123,610 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,412,923 | 122,314 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $6,416,063 | 123,934 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,354,559 | 124,548 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $5,620,761 | 130,685 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,370,715 | 137,148 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $4,962,097 | 136,961 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,314,959 | 144,389 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,161,189 | 140,632 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,666,523 | 142,707 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,672,964 | 143,167 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||